Lung cancer: potential targets for immunotherapy
- 1 September 2013
- journal article
- review article
- Published by Elsevier BV in The Lancet Respiratory Medicine
- Vol. 1 (7), 551-563
- https://doi.org/10.1016/s2213-2600(13)70159-0
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- Immunotherapies for non-small-cell lung cancer and mesotheliomaThe Lancet Oncology, 2012
- The secret ally: immunostimulation by anticancer drugsNature Reviews Drug Discovery, 2012
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJama-Journal Of The American Medical Association, 2011
- Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of IdoNature Medicine, 2011
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumorsNature Medicine, 2011
- Epidemiologic perspective on immune-surveillance in cancerCurrent Opinion in Immunology, 2011
- CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene InactivationCancer Cell, 2010
- Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patientsLung Cancer, 2010
- Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cellsLung Cancer, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007